CAS: 876126-60-2 - 4-Amino-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide
Formula:C14H21N3O2
InChI:InChI=1S/C14H21N3O2/c1-17-7-5-11(6-8-17)16-14(18)10-3-4-12(15)13(9-10)19-2/h3-4,9,11H,5-8,15H2,1-2H3,(H,16,18)
InChI key:InChIKey=XBYFLVPPIOYEJF-UHFFFAOYSA-N
SMILES:O=C(NC1CCN(C)CC1)C2=CC=C(N)C(OC)=C2
- Synonyms:
- Benzamide, 4-amino-3-methoxy-N-(1-methyl-4-piperidinyl)-
- 4-Amino-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
- 4-Amino-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Benzamide, 4-amino-3-methoxy-N-(1-methyl-4-piperidinyl)- REF: IN-DA00IEP7CAS: 876126-60-2 | % | 190.00 €~513.00 € | Tue 21 Jan 25 |
 | 4-AMINO-3-METHOXY-N-(1-METHYLPIPERIDIN-4-YL)BENZAMIDE REF: 10-F473794CAS: 876126-60-2 | 95.0% | 152.00 €~534.00 € | Thu 23 Jan 25 |
 | 4-Amino-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide REF: 3D-FA179191CAS: 876126-60-2 | Min. 95% | - - - | Discontinued product |
Benzamide, 4-amino-3-methoxy-N-(1-methyl-4-piperidinyl)-
CAS:876126-60-2
Formula:
C14H21N3O2
Purity:
%
Color and Shape:
Solid
Molecular weight:
263.3354
Ref: IN-DA00IEP7
| 1g | 513.00 € | ||
| 100mg | 190.00 € | ||
| 250mg | 225.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
4-AMINO-3-METHOXY-N-(1-METHYLPIPERIDIN-4-YL)BENZAMIDE
CAS:876126-60-2
Purity:
95.0%
Molecular weight:
263.34100341796875
Ref: 10-F473794
| 1g | 534.00 € | ||
| 100mg | 152.00 € | ||
| 250mg | 245.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
4-Amino-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide
CAS:876126-60-2
Please enquire for more information about 4-Amino-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide including the price, delivery time and more detailed …
Formula:
C14H21N3O2
Purity:
Min. 95%
Molecular weight:
263.34 g/mol
Ref: 3D-FA179191
| 1g | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
